Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP
Alexandar Tzankov(The University of Texas MD Anderson Cancer Center), Zijun Y. Xu‐Monette(The University of Texas MD Anderson Cancer Center), Marc Gerhard(University Hospital of Basel), Carlo Visco(Ospedale San Bortolo), Stephan Dirnhofer(University Hospital of Basel), Nora Gisin(University Hospital of Basel), Karen Dybkær(Aalborg University Hospital), Attilio Orazi(Cornell University), Govind Bhagat(Columbia University Irving Medical Center), Kristy L. Richards(University of North Carolina at Chapel Hill), Eric D. Hsi(Cleveland Clinic), William W.L. Choi(Chinese University of Hong Kong), J. Han van Krieken(Radboud University Nijmegen), Maurilio Ponzoni, Andrés JM Ferreri, Qing Ye(Nanjing Drum Tower Hospital), Jane N. Winter(Northwestern University), John P. Farnen(Gundersen Health System), Miguel Á. Piris(Fundación Marques de Valdecilla), Michael Møller(Odense University Hospital), M. James You(The University of Texas MD Anderson Cancer Center), Timothy J. McDonnell(The University of Texas MD Anderson Cancer Center), L. Jeffrey Medeiros(The University of Texas MD Anderson Cancer Center), Ken H. Young(The University of Texas MD Anderson Cancer Center)
Cited by 128Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis